CHINAGOLDINTL (02099) announces a net profit of approximately $472 million in 2025, a year-on-year increase of 623.32%. It will distribute $0.47 per share.
China Gold International (02099) announced its performance for 2025, with sales revenue of about $1.31 billion, a year-on-year increase of 73.15%; net profit of about $472 million, a year-on-year increase of 623.32%; attributable net profit to company owners of about $467 million, a year-on-year increase of 644.37%; basic earnings per share of $0.1178, intending to distribute dividends of $0.47 per share. Operating cash flow was $710 million, with total gold production increasing by 9% to about 177,200 ounces, and total copper production increasing by 48% year-on-year to 156.3 million pounds (about 70,883 metric tons).
CHINAGOLDINTL (02099) announced its performance for the year 2025, with sales revenue of approximately 1.31 billion US dollars, a year-on-year increase of 73.15%; net profit of about 472 million US dollars, a year-on-year increase of 623.32%; attributable net profit to owners of the company of about 467 million US dollars, a year-on-year increase of 644.37%; basic earnings per share of 117.80 US cents, with a proposed dividend of 0.47 US dollars per share. Operating cash flow amounted to 710 million US dollars, with total gold production increasing by 9% year-on-year to approximately 177,200 ounces, and total copper production increasing by 48% year-on-year to 156.3 million pounds (about 70,883 tons).
For the year 2026, the estimated total gold production at the Changshan Hao mine is between 70,732 ounces (2.2 tons) to 83,592 ounces (2.6 tons). The production of copper at the Jiamamu mine is expected to be around 140 million pounds (63,500 tons) to 149 million pounds (67,500 tons); gold production will be approximately 70,732 ounces (2.2 tons) to 75,554 ounces (2.35 tons); silver production will be about 4.18 million ounces (130 tons) to 4.82 million ounces (150 tons).
Related Articles

China Glass (03300) announced a net loss attributable to equity shareholders of approximately RMB 4.893 billion in 2025, representing an increase of about 4.58 times year-on-year.

CITIC SEC: The value of energy security is highlighted, and public utilities are expected to benefit from reevaluation

SSY GROUP(02005): Upatinib has been approved by the China Food and Drug Administration for registration as an active pharmaceutical ingredient for use in marketed preparations.
China Glass (03300) announced a net loss attributable to equity shareholders of approximately RMB 4.893 billion in 2025, representing an increase of about 4.58 times year-on-year.

CITIC SEC: The value of energy security is highlighted, and public utilities are expected to benefit from reevaluation

SSY GROUP(02005): Upatinib has been approved by the China Food and Drug Administration for registration as an active pharmaceutical ingredient for use in marketed preparations.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


